The effect of artificial sweeteners on glycemic parameters of type 2 diabetes
Development of instruments to measure habitual dietary intake in large epidemiological studies has been investigated extensively. The purpose of this study was to develop a computer-assisted personal interview system (CAPI) system for conducting dietaryassessment. A 168-item food frequency questionnaire (FFQ), originally developed for the Tehran Lipid and Glucose Study, is used widely in food and nutrition studies in Iran. In addition to measurement errors at data recording and entry levels, the printed form is time-consuming and costly, both financially and environmentally. This technical reportintroduces a computer-assisted personal interviewing (CAPI) program to collect food and nutrition data using the Iranian 168-item FFQ. The U.S. Census Bureau’s CSPro software was used to construct the CAPI application. The application runs on Android devices andcomputers with Microsoft Windows operating systems. The language of the CAPI is Farsi. This easy-to-use CAPI tool attempts to reduce time, cost, and human error in nationwide and local nutrition research.
Zimmet P, Alberti KG, Magliano DJ, Bennett PH. Diabetes mellitus statistics on prevalence and mortality: facts and fallacies. Nature Reviews Endocrinology. 2016.
Sandu M-M, Protasiewicz DC, Firănescu AG, Lăcătuşu EC, Bîcu ML, Moţa M. Data regarding the prevalence and incidence of diabetes mellitus and prediabetes. Romanian Journal of Diabetes Nutrition and Metabolic Diseases. 2016:23(1):95-103.
Najafipour F, Azizi F, Zareizadeh M. EPIDEMIOLOGICAL STUDY OF FAMILIAL DIABETES TYPE 2 IN TEHRAN. Journal of Diabetes and Metabolic Disorders. 2004:4(0):83.
Najafipour F, Zareizadeh M. PREVALENCE OF DM–IGT AND IFG IN FIRST DEGREE RELATIVE FAMILY MEMBERS OF TYPE 2 DIABETES IN TABRIZ. Iranian Journal of Diabetes and Metabolism. 2004:4(1):51-57.
Yoon K-H, Lee J-H, Kim J-W, Cho JH, Choi Y-H, Ko S-H, et al. Epidemic obesity and type 2 diabetes in Asia. The Lancet. 2006:368(9548):1681-88.
Group DPPR. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl j Med. 2002:2002(346):393-403.
Sharma A, Amarnath S, Thulasimani M, Ramaswamy S. Artificial sweeteners as a sugar substitute: Are they really safe? Indian journal of pharmacology. 2016:48(3):237.
Tandel KR. Sugar substitutes: Health controversy over perceived benefits. Journal of pharmacology & pharmacotherapeutics. 2011:2(4):236.
Romo-Romo A, Aguilar-Salinas CA, Brito-Córdova GX, Díaz RAG, Valentín DV, Almeda-Valdes P. Effects of the non-nutritive sweeteners on glucose metabolism and appetite regulating hormones: Systematic review of observational prospective studies and clinical trials. PloS one. 2016:11(8).
Evert AB, Boucher JL, Cypress M, Dunbar SA, Franz MJ, Mayer-Davis EJ, et al. Nutrition therapy recommendations for the management of adults with diabetes. Diabetes care. 2013:36(11):3821-42.
Federation ID. IDF Diabetes Atlas Update Poster. International Diabetes Federation; Brussels, Belgium2014.
Shankar P, Ahuja S, Sriram K. Non-nutritive sweeteners: review and update. Nutrition. 2013:29(11):1293-99.
Vermunt S, Pasman W, Schaafsma G, Kardinaal A. Effects of sugar intake on body weight: a review. obesity reviews. 2003:4(2):91-99.
De Koning L, Malik VS, Rimm EB, Willett WC, Hu FB. Sugar-sweetened and artificially sweetened beverage consumption and risk of type 2 diabetes in men. The American journal of clinical nutrition. 2011:93(6):1321-27.
Imamura F, O’Connor L, Ye Z, Mursu J, Hayashino Y, Bhupathiraju SN, et al. Consumption of sugar sweetened beverages, artificially sweetened beverages, and fruit juice and incidence of type 2 diabetes: systematic review, meta-analysis, and estimation of population attributable fraction. Bmj. 2015:351:h3576.
Gardner C, Wylie-Rosett J, Gidding SS, Steffen LM, Johnson RK, Reader D, et al. Nonnutritive sweeteners: current use and health perspectives. Circulation. 2012:126(4):509-19.
Raben A, Vasilaras TH, Møller AC, Astrup A. Sucrose compared with artificial sweeteners: different effects on ad libitum food intake and body weight after 10 wk of supplementation in overweight subjects. The American journal of clinical nutrition. 2002:76(4):721-29.
Malik VS, Popkin BM, Bray GA, Després J-P, Willett WC, Hu FB. Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes. Diabetes care. 2010:33(11):2477-83.
Mishra A, Ahmed K, Froghi S, Dasgupta P. Systematic review of the relationship between artificial sweetener consumption and cancer in humans: analysis of 599,741 participants. International journal of clinical practice. 2015:69(12):1418-26.
Ibrahim OO. High intensity sweeteners chemicals structure, properties and applications. Natural Science and Discovery. 2015:1(4):88-94.
Fitch C, Keim KS. Position of the Academy of Nutrition and Dietetics: use of nutritive and nonnutritive sweeteners. Journal of the Academy of Nutrition and Dietetics. 2012:112(5):739-58.
Tordoff MG, Alleva AM. Effect of drinking soda sweetened with aspartame or high-fructose corn syrup on food intake and body weight. The American Journal of Clinical Nutrition. 1990:51(6):963-69.
Horwitz DL, McLane M, Kobe P. Response to single dose of aspartame or saccharin by NIDDM patients. Diabetes care. 1988:11(3):230-34.
Nettleton JA, Lutsey PL, Wang Y, Lima JA, Michos ED, Jacobs DR. Diet soda intake and risk of incident metabolic syndrome and type 2 diabetes in the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes care. 2009:32(4):688-94.
Roberts A, Renwick A, Sims J, Snodin D. Sucralose metabolism and pharmacokinetics in man. Food and chemical toxicology. 2000:38:31-41.
Byard J, Golberg L. The metabolism of saccharin in laboratory animals. Food and cosmetics toxicology. 1973:11(3):391-402.
Clemente JC, Ursell LK, Parfrey LW, Knight R. The impact of the gut microbiota on human health: an integrative view. Cell. 2012:148(6):1258-70.
Claesson MJ, Jeffery IB, Conde S, Power SE, O’Connor EM, Cusack S, et al. Gut microbiota composition correlates with diet and health in the elderly. Nature. 2012:488(7410):178-84.
Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. nature. 2006:444(7122):1027-131.
Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature. 2006:444(7122):1022.
Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012:490(7418):55-60.
Henao-Mejia J, Elinav E, Jin C, Hao L, Mehal WZ, Strowig T, et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature. 2012:482(7384):179-85.
Festi D, Schiumerini R, Eusebi LH, Marasco G, Taddia M, Colecchia A. Gut microbiota and metabolic syndrome. World journal of gastroenterology: WJG. 2014:20(43):16079.
|Issue||Vol 3, No 3 (Summer 2017)|
|type 2 Diabetes fasting blood glucose 2 hour post prandial blood glucose Hb A1C Artificial sweeteners|
|Rights and permissions|
|This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.|